Human QSOX2/QSCN6L1/SOXN ORF/cDNA clone-Lentivirus particle (NM_181701.4)

Cat. No.: vGMLV001675

Pre-made Human QSOX2/QSCN6L1/SOXN Lentiviral expression plasmid for QSOX2 lentivirus packaging, QSOX2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to QSOX2/QSCN6L1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLV001675 Human QSOX2 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLV001675
Gene Name QSOX2
Accession Number NM_181701.4
Gene ID 169714
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2097 bp
Gene Alias QSCN6L1,SOXN
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCGGCGGCCGGGGCGGCGGTGGCGCGCAGCCCGGGAATCGGAGCGGGACCTGCGCTGAGAGCCCGGCGCTCGCCCCCGCCGCGGGCCGCACGGCTGCCGCGGCTGCTAGTGCTGCTAGCGGCGGCGGCGGTGGGGCCGGGCGCGGGCGGTGCGGCGCGGCTGTACCGCGCGGGCGAGGACGCCGTGTGGGTGCTGGACAGCGGCAGCGTGCGCGGGGCCACCGCCAACAGCTCGGCCGCGTGGCTCGTGCAGTTCTACTCGTCGTGGTGTGGCCACTGCATCGGCTACGCGCCCACTTGGCGGGCCCTGGCTGGGGATGTGCGAGACTGGGCCAGTGCCATTCGCGTCGCAGCTCTGGACTGCATGGAAGAGAAGAACCAGGCCGTGTGCCATGACTACGACATCCACTTCTACCCCACCTTCCGGTATTTTAAAGCATTTACAAAGGAGTTTACAACTGGAGAAAATTTTAAAGGACCTGACCGAGAGCTGCGAACAGTCAGACAGACGATGATTGACTTCCTGCAGAACCACACGGAAGGAAGCCGGCCCCCTGCCTGCCCGCGCCTAGACCCCATTCAGCCCAGTGATGTTCTTTCCCTTCTTGACAACCGTGGCAGCCATTACGTGGCTATTGTCTTTGAAAGCAACAGCTCCTACCTTGGACGGGAGGTGATCTTAGACCTGATCCCGTATGAAAGCATCGTGGTGACCCGAGCACTGGACGGGGACAAAGCATTTCTGGAGAAACTTGGTGTTTCTTCAGTCCCTTCGTGTTACCTGATCTACCCAAATGGGTCGCATGGATTGATTAACGTCGTGAAGCCTCTGCGGGCCTTCTTTTCGTCTTATTTGAAGTCATTGCCGGATGTGAGGAAAAAATCGCTTCCCTTGCCTGAAAAGCCACACAAAGAAGAAAATTCAGAAATCGTGGTTTGGAGAGAATTTGACAAGTCGAAGCTGTACACGGTGGACCTGGAGTCAGGGCTACACTACCTCCTGCGGGTGGAGCTGGCAGCCCACAAGTCCCTGGCCGGAGCAGAGCTGAAGACGCTCAAGGACTTTGTGACTGTCTTGGCCAAGCTGTTCCCTGGACGGCCGCCAGTCAAGAAGCTGTTGGAGATGCTGCAGGAGTGGCTGGCCAGCCTTCCCCTGGACAGGATCCCCTACAACGCCGTGCTTGACCTGGTCAACAACAAGATGCGGATTTCTGGAATATTCCTTACTAATCACATAAAGTGGGTTGGATGTCAAGGAAGCCGATCTGAGTTGAGGGGTTACCCGTGTTCTCTCTGGAAACTGTTCCACACTTTGACTGTTGAAGCCTCGACCCACCCAGATGCACTGGTTGGCACAGGCTTTGAAGACGACCCCCAGGCTGTGCTGCAGACAATGAGGAGGTACGTTCACACCTTCTTTGGGTGTAAGGAATGTGGTGAGCACTTTGAGGAAATGGCTAAAGAATCCATGGACTCGGTGAAAACCCCAGACCAAGCCATCCTCTGGCTGTGGAAGAAGCATAATATGGTGAACGGCCGCCTGGCAGGCCATCTGAGTGAGGATCCCCGGTTTCCAAAGCTTCAGTGGCCCACTCCGGACCTCTGCCCAGCCTGCCATGAGGAAATTAAGGGCCTGGCCAGCTGGGATGAAGGCCACGTGCTCACATTCTTGAAGCAGCACTATGGCCGCGACAACCTCTTAGACACGTATTCCGCAGACCAGGGGGATTCCAGTGAAGGAGGAACCCTGGCCAGGGGTGAGGAAGAGGAGAAAAGACTCACTCCCCCAGAGGTGTCCCATGGAGACCGAGACACCCAGAGCGTCCGTCCACCTGGTGCACTGGGCCCCAGGCCTGCCCTTCCAGAGAGCTTGCATCACAGCTTGGACGGGAAACTCCAGAGTCTGGATGGGCCCGGGGCCCACAAGGAGGTGGGCGGGGCCGCACCCTTCCTCGGGGTTGACTTCTCCAGCCTGGACATGAGTCTCTGTGTCGTGCTGTACGTGGCTTCATCCCTGTTCCTCATGGTGATGTACTTCTTCTTCCGGGTGAGGTCCAGGCGGTGGAAGGTCAAGCACCACCACCCGGCCGTGTGA
ORF Protein Sequence MAAAGAAVARSPGIGAGPALRARRSPPPRAARLPRLLVLLAAAAVGPGAGGAARLYRAGEDAVWVLDSGSVRGATANSSAAWLVQFYSSWCGHCIGYAPTWRALAGDVRDWASAIRVAALDCMEEKNQAVCHDYDIHFYPTFRYFKAFTKEFTTGENFKGPDRELRTVRQTMIDFLQNHTEGSRPPACPRLDPIQPSDVLSLLDNRGSHYVAIVFESNSSYLGREVILDLIPYESIVVTRALDGDKAFLEKLGVSSVPSCYLIYPNGSHGLINVVKPLRAFFSSYLKSLPDVRKKSLPLPEKPHKEENSEIVVWREFDKSKLYTVDLESGLHYLLRVELAAHKSLAGAELKTLKDFVTVLAKLFPGRPPVKKLLEMLQEWLASLPLDRIPYNAVLDLVNNKMRISGIFLTNHIKWVGCQGSRSELRGYPCSLWKLFHTLTVEASTHPDALVGTGFEDDPQAVLQTMRRYVHTFFGCKECGEHFEEMAKESMDSVKTPDQAILWLWKKHNMVNGRLAGHLSEDPRFPKLQWPTPDLCPACHEEIKGLASWDEGHVLTFLKQHYGRDNLLDTYSADQGDSSEGGTLARGEEEEKRLTPPEVSHGDRDTQSVRPPGALGPRPALPESLHHSLDGKLQSLDGPGAHKEVGGAAPFLGVDFSSLDMSLCVVLYVASSLFLMVMYFFFRVRSRRWKVKHHHPAV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP1443-Ab Anti-QSOX2/ QSCN6L1/ SOXN monoclonal antibody
    Target Antigen GM-Tg-g-MP1443-Ag QSOX2 VLP (virus-like particle)
    ORF Viral Vector pGMLV001675 Human QSOX2 Lentivirus plasmid
    ORF Viral Vector vGMLV001675 Human QSOX2 Lentivirus particle


    Target information

    Target ID GM-MP1443
    Target Name QSOX2
    Gene ID 169714, 227638, 721768, 681023, 101092406, 607571, 788063, 102147928
    Gene Symbol and Synonyms QSCN6L1,QSOX2,SOXN
    Uniprot Accession Q6ZRP7
    Uniprot Entry Name QSOX2_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000165661
    Target Classification Not Available

    QSOX2 is a member of the sulfhydryl oxidase/quiescin-6 (Q6) family (QSOX1; MIM 603120) that regulates the sensitization of neuroblastoma cells for IFN-gamma (IFNG; MIM 147570)-induced cell death (Wittke et al., 2003 [PubMed 14633699]).[supplied by OMIM, Jun 2009]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.